Recovery Control Tower Feasibility Pilot
Launched by WASHINGTON UNIVERSITY SCHOOL OF MEDICINE · Dec 9, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Recovery Control Tower Feasibility Pilot is a study looking at how telemedicine can help patients after elective surgery. This means that instead of always needing to see a doctor in person, patients might be able to have some of their care and follow-up done through video calls or other remote methods. The goal is to see if this approach is not only efficient and safe but also helps improve the recovery experience for patients in the Post-Anesthesia Care Unit (PACU). If this pilot is successful, the researchers plan to expand this method to other hospitals.
To be part of this study, you need to be an adult (18 years or older) who is scheduled for elective surgery at Barnes Jewish Hospital in St. Louis, Missouri. If you join the study, you can expect to receive care that might include using telemedicine tools to check on your recovery after surgery. This pilot study is currently looking for participants, and everyone, regardless of gender, is welcome to apply.
Gender
ALL
Eligibility criteria
- • Adults (18 years and older)
- • Undergoing elective surgery at Barnes Jewish Hospital in St. Louis, Missouri will be enrolled.
About Washington University School Of Medicine
Washington University School of Medicine is a leading academic medical institution renowned for its commitment to advancing healthcare through innovative research, education, and patient care. With a strong emphasis on translating scientific discoveries into practical applications, the institution conducts a diverse array of clinical trials aimed at improving treatment outcomes and enhancing the understanding of various medical conditions. Its collaborative environment fosters partnerships between researchers, clinicians, and community stakeholders, ensuring that the trials not only contribute to scientific knowledge but also address the pressing health needs of diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Saint Louis, Missouri, United States
Patients applied
Trial Officials
Michael S Avidan, MBBcH
Principal Investigator
Washington University School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported